MedPath

BSSPlus Versus Lactated Ringer's for Phacoemulsification

Phase 2
Completed
Conditions
Cataract
Interventions
Procedure: Phacoemulsification
Drug: BSSPlus solution
Drug: Lactated Ringer's solution
Registration Number
NCT00801359
Lead Sponsor
University of Sao Paulo
Brief Summary

Two intraocular irrigating solutions (BSSPlus versus Lactated Ringer's) are compared in this prospective, randomized, masked trial to investigate for differences in preservation of corneal integrity after phacoemulsification cataract surgery.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
110
Inclusion Criteria
  • Patients with senile cataract
  • Visual acuity between 20/400 and 20/40
Exclusion Criteria
  • Presence of corneal opacity
  • Presence of corneal disease
  • Traumatic, toxic, hereditary (congenital)and complicated cataracts(uveitis)
  • Anterior chamber cells or flare detected before surgery
  • Previous ocular surgery
  • Any condition which may affect documentation or follow-up

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
BSSplusBSSPlus solution-
RingerPhacoemulsification-
BSSplusPhacoemulsification-
RingerLactated Ringer's solution-
Primary Outcome Measures
NameTimeMethod
endothelial cell densitybaseline and at 1, 8, 15, 30 and 60 days postoperatively
central corneal thicknessbaseline and at 1, 8, 15, 30 and 60 days postoperatively
Secondary Outcome Measures
NameTimeMethod
number of anterior chamber cells and flare gradebaseline and at 1, 8, 15, 30 and 60 days postoperatively

Trial Locations

Locations (1)

Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto; Centro Avançado de Retina e Catarata

🇧🇷

Ribeirão Preto, São Paulo, Brazil

© Copyright 2025. All Rights Reserved by MedPath